Evidence of chronic chlamydia pneumoniae infection in patients with Behçet's disease

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 6-7, 2004, Pages 428-430

  Ayaşlioǧlu, Ergin ^a,d   Düzgün, Nurşen ^b   Erkek, Emel ^a   Inal, Ali ^c  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOSPORIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BEHCET DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; SEROLOGY; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BEHCET SYNDROME; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED;

EID: 4143149601     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410020730     Document Type: Article

References (26)

1. Jorizzo JL, Abernethy JL, White WL, Mangelsdorf HC, Zouboulis CC, Sarica R, et al. Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathological data from multiple international centres. J Am Acad Dermatol 1995; 32: 968-76.
2. Ayaslioglu E, Erkek E, Kilic D, Kaygusuz S, Karaca F, Duzgun N. Tetanus antitoxin seroprevalence in patients with Behcet's disease. Scand J Infect Dis 2003; 35: 299-301.
3. Sakane T, Suzuki N, Nagafuchi H. Aetiopathology of Behçet's disease: immunological aspects. Yonsei Med J 1997; 38: 350-8.
4. Önder M, Gürer MA. The multiple faces of Behçet's disease and its aetiological factors. J Eur Acad Dermatol 2001; 15: 126-36.
5. Gencay M, Jochen JR, Tamm M, Soler M, Perruchoud AP, Roth M. Increased frequency of Chlamydia pneumoniae anti-bodies in patients with asthma. Am J Resp Crit Care Med 2000; 163: 1097-2006.
6. Hertzan L, Vasankari T, Liippo K, Wahlström E, Puolakkainen M. Chlamydia pneumoniae and severity of asthma. Scand J Infect Dis 2002; 34: 22-7.
7. Hahn D. Chlamydia pneumoniae, asthma, and COPD: what is the evidence? Ann Allergy Asthma Immunol 1999; 83: 271-88.
8. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-6.
9. Taylor-Robinson D, Thomas BJ. Chlamydia pneumoniae in atherosclerotic tissue. J Infect Dis 2000; 181(Suppl 3): 437-40.
10. Schumacher A, Seljeflot I, Lerkerod AB, Sommervoll L, Otterstad JE, Arnesen H. Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? Clin Microbiol Infect 2002; 8: 654-61.
11. Ljungstrom L, Franzen C, Schlaug M, Elowson S, Viidas U. Reinfection with Chlamydia pneumoniae may induce isolated and systemic vasculitis in small and large vessels. Scand J Infect Dis Suppl 1997; 104: 37-40.
12. Cascina A, Marone Bianco A, Mangiarotti P, Montecucco CM, Meloni F. Cutaneous vasculitis and reactive arthritis following respiratory infection due to Chlamydia pneumoniae: report of a case. Clin Exp Rheumatol 2002; 20: 845-7.
13. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
14. Koivisto AL, Isoaho R, Von Hertzen L, Toyryla M, Laippala P, Kivela SL, Saikku P. Chlamydial antibodies in an elderly Finnish population. Scand J Infect Dis 1999; 31: 135-9.
15. Saikku P, Wang SP, Kleemola M, Brander E, Rusanen E, Grayston JT. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 1985; 151: 832-9.
16. Sundelof B, Gnarpe H, Gnarpe J. An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum. Scand J Infect Dis 1993; 25: 259-61.
17. Gran JT, Hjetland R, Andreassen AH. Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae. Scand J Rheumatol 1993; 22: 43-4.
18. Halme S, Juvonen T, Laurila A, Juvonen J, Mosorin M, Saikku P, Surcel HM. Chlamydia pneumoniae reactive T-lymphocytes in the walls of abdominal aortic aneurysms. Eur J Clin Invest 1999; 29: 546-52.
19. Wagner AD, Gerard HC, Fresemann T, Schmidt WA, Gromnica-Ihle E, Hudson AP, Zeidler H. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum 2000; 43: 1543-51.
20. Koster T, Rosendaal FR, Lieuw-A-Len DD, Kroes AC, Emmerich JD, van Dissel JT. Chlamydia pneumoniae IgG seropositivity and risk of deep-vein thrombosis. Lancet 2000; 355: 1694-5.
21. Kaukoranta-Tolvanen SS, Laitinen K, Saikku P, Leinonen M. Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog 1994; 16: 313-9.
22. Curry AJ, Portig I, Goodall JC, Kirkpatrick PJ, Gaston JS. T-lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens. Clin Exp Immunol 2000; 12: 261-9.
23. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, et al. C. pneumoniae Workshop participants. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada), Clin Infect Dis 200; 33: 492-503.
24. Schumacher A, Lerkerod AB, Seljeflot I, Sommervoll L, Holme I, Otterstad JE, Arnesen H. Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol 2000; 39: 1859-64.
25. Tapia O, Slepenkin A, Sevrioukov E, Hamor K, de la Maza LM, Peterson EM. Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae. Clin Diagn Lab Immunol 2002; 9: 562-7.
26. Hermann C, Graf K, Groh A, Straube E, Hartung T. Comparison of 11 commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol 2002; 40: 1603-9.